Researchers have demonstrated the feasibility of utilizing tumor sequencing when guiding chemotherapy in early-breast cancer patients.
Browsing: Taxonomy > Chemotherapy
In this systematic review from Pharmacogenomics find out about the influence pharmacogenetics and ethnicity can have on oxaliplatin therapy for colorectal cancer.
Researchers have developed a calculator that reasonably predicts which esophageal adenocarcinoma patients may gain overall survival benefit from neoadjuvant chemoradiation.
How have transarterial therapies for hepatocellular carcinoma evolved over recent years? What impact have these changes had on patient outcomes? Read more in our partner journal Hepatic Oncology.
Researchers have discovered that a drug, normally utilized to prevent infections in cancer patients after treatment, may also prevent chemotherapy-induced infertility in males.
Researchers have uncovered the potential overuse of chemotherapy in young and middle-aged colon cancer patients.
In this special report from Future Oncology, the interplay between prognostic factors, predictive markers and cancer biology are discussed in relation to chemoprevention strategies for oral cancer.
New clinical trial data indicates that pembrolizumab immunotherapy both significantly increases survival in bladder cancer and has activity against mucosal melanoma.
Data presented at the 2017 European Cancer Congress highlights how twice-daily hypofractionated radiotherapy and chemotherapy in head and neck cancer could reduce recurrence and mortality in head and neck cancer.
Researchers have demonstrated that administering neoadjuvant chemotherapy prior to surgery may improve patient outcomes for African-American breast cancer patients.